Company Filing History:
1 out of 1,209 
1 out of 9 Years Active: 2025
Title: Yeonsil Kim: Innovator in Neurodegenerative Disease Treatment
Introduction
Yeonsil Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurodegenerative diseases.
Latest Patents
Yeonsil Kim holds a patent for "Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2." This patent discloses compounds that possess inhibitory activity against LRRK2. Additionally, it includes pharmaceutical compositions containing these compounds and methods for using them to treat neurodegenerative diseases and disorders, such as Parkinson's disease and brain cancer, including gliomas and glioblastomas. He has 1 patent to his name.
Career Highlights
Throughout his career, Yeonsil Kim has worked with notable institutions, including the Dana-Farber Cancer Institute and Voronoi Inc. His work has focused on innovative solutions to complex medical challenges, particularly in the realm of cancer and neurodegenerative disorders.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Yeonsil Kim's contributions to the field of neurodegenerative disease treatment through his innovative patents highlight his role as a key figure in medical research and development. His work continues to pave the way for advancements in the treatment of serious health conditions.